Metraipolis › archive › dc_0218ae993e90
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder — Europe PMC PMID:41869622
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41869622
- DOI
- 10.3389/fpubh.2026.1774410
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T03:36:32.747Z
- SHA-256 of the archived text
d75eb910fcb79a205eab2cd557c8e24b242086b7396ecb0de97b31af11c517e8- Stable URL of this page
https://metraipolis.com/documento/dc_0218ae993e90
How to cite
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder — Europe PMC PMID:41869622 — Europe PMC (en), https://europepmc.org/article/MED/41869622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0218ae993e90 (Metraipolis archive dc_0218ae993e90, sha256 d75eb910fcb79a205eab2cd557c8e24b242086b7396ecb0de97b31af11c517e8)
BibTeX
@misc{dc0218ae993e90,
title = {Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder — Europe PMC PMID:41869622},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41869622},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0218ae993e90; sha256 d75eb910fcb79a205eab2cd557c8e24b242086b7396ecb0de97b31af11c517e8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869622. Agents can read the archived copy with the MCP tool read_document.